Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Sirano Dhe-Paganon
Affiliation
Dana-Farber Cancer Institute
ORCID
Career Start Year
1989
Papers
125
H Index
49
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36823301
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease.
Nat Med
2023
37595760
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance.
J Allergy Clin Immunol
2023
37267907
Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90α.
Mol Cell
2023
36788219
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice.
NPJ Vaccines
2023
36921622
Lactate regulates cell cycle by remodelling the anaphase promoting complex.
Nature
2023
36869134
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice.
NPJ Vaccines
2023
36823351
Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor.
Nat Chem Biol
2023
34783582
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.
Sci Transl Med
2022
35760926
Structural basis for defective membrane targeting of mutant enzyme in human VLCAD deficiency.
Nat Commun
2022
35860217
Adjuvant Discovery via a High Throughput Screen using Human Primary Mononuclear Cells.
bioRxiv
2022
35486727
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer.
Sci Adv
2022
36523401
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance.
bioRxiv
2022
35933439
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant.
Commun Biol
2022
36305736
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma.
Cancer Discov
2022
36355493
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.
Pharmaceuticals (Basel)
2022
36300789
Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling.
Elife
2022
35148840
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity.
Cell
2022
33273722
Author Correction: The nucleosome acidic patch and H2A ubiquitination underlie mSWI/SNF recruitment in synovial sarcoma.
Nat Struct Mol Biol
2021
34413960
Exploring Ligand-Directed <i>N</i>-Acyl-<i>N</i>-alkylsulfonamide-Based Acylation Chemistry for Potential Targeted Degrader Development.
ACS Med Chem Lett
2021
34129829
Identification and validation of selective deubiquitinase inhibitors.
Cell Chem Biol
2021
34031655
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity.
bioRxiv
2021
33972797
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo.
Nat Chem Biol
2021
33284322
Binding and transport of SFPQ-RNA granules by KIF5A/KLC1 motors promotes axon survival.
J Cell Biol
2021
32483379
Identification of a potent and selective covalent Pin1 inhibitor.
Nat Chem Biol
2020
33242418
Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.
Cell
2020
32747783
The nucleosome acidic patch and H2A ubiquitination underlie mSWI/SNF recruitment in synovial sarcoma.
Nat Struct Mol Biol
2020
32694660
Glucose-dependent partitioning of arginine to the urea cycle protects β-cells from inflammation.
Nat Metab
2020
32359398
Identification of a Structural Determinant for Selective Targeting of HDMX.
Structure
2020
32413285
Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide Tethering.
Cell Chem Biol
2020
32210275
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.
Sci Rep
2020
32433464
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities.
Nat Commun
2020
32298120
Discovery and Structure-Activity Relationship Study of (<i>Z</i>)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors.
J Med Chem
2020
31620231
Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold.
ACS Med Chem Lett
2019
31717342
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
Cancers (Basel)
2019
31759698
Recurrent SMARCB1 Mutations Reveal a Nucleosome Acidic Patch Interaction Site That Potentiates mSWI/SNF Complex Chromatin Remodeling.
Cell
2019
32184968
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors.
ACS Med Chem Lett
2019
31175292
Structural and functional consequences of the STAT5B<sup>N642H</sup> driver mutation.
Nat Commun
2019
29276033
Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.
Structure
2018
30093655
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells.
Nat Commun
2018
30065030
Islet-Derived eATP Fuels Autoreactive CD8<sup>+</sup> T Cells and Facilitates the Onset of Type 1 Diabetes.
Diabetes
2018
30010623
P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes.
J Clin Invest
2018
29507391
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands.
Nat Chem Biol
2018
28926338
MELK is not necessary for the proliferation of basal-like breast cancer cells.
Elife
2017
28082445
p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma.
Blood
2017
28241139
Transcription control by the ENL YEATS domain in acute leukaemia.
Nature
2017
28418626
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.
Angew Chem Int Ed Engl
2017
28967922
Inhibition of USP10 induces degradation of oncogenic FLT3.
Nat Chem Biol
2017
29056421
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.
Cell Chem Biol
2017
26947396
Data publication with the structural biology data grid supports live analysis.
Nat Commun
2016
28193034
Leveraging Gas-Phase Fragmentation Pathways for Improved Identification and Selective Detection of Targets Modified by Covalent Probes.
Anal Chem
2016
1 - 50 of 125
Column Actions
Search
Recommended Authors
Dennis Goldfarb
Washington University School of Medicine
Career Start Year
2012
Number of shared co-authors
1
Lisa M Miller Jenkins
National Cancer Institute, National Institutes of Health
Career Start Year
2005
Number of shared co-authors
1
Shawn S-C Li
University of Western Ontario
Career Start Year
2002
Number of shared co-authors
8
Alan M Sandercock
MedImmune Ltd.
Career Start Year
2001
Number of shared co-authors
2
Andrew P VanDemark
University of Pittsburgh
Career Start Year
2000
Number of shared co-authors
0
Jeroen A A Demmers
Erasmus Medical Center
Career Start Year
2000
Number of shared co-authors
0
Feixia Chu
University of New Hampshire
Career Start Year
1999
Number of shared co-authors
3
Rachel Toth
University of Dundee
Career Start Year
1999
Number of shared co-authors
7
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
7
Udupi A Ramagopal
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year
1998
Number of shared co-authors
9
Erik Verschueren
University of California San Francisco
Career Start Year
1997
Number of shared co-authors
4
Damarys Loew
Institut Curie, PSL Research University
Career Start Year
1996
Number of shared co-authors
0
Krzysztof Paw??owski
Kashubian Center for Heart and Vascular Diseases in Wejherowo, Pomeranian Hospitals
Career Start Year
1996
Number of shared co-authors
0
Luis Sanchez-Pulido
MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh
Career Start Year
1996
Number of shared co-authors
7
Ning Zheng
University of Washington
Career Start Year
1996
Number of shared co-authors
2
Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute
Career Start Year
1994
Number of shared co-authors
18
James C Whisstock
Monash University
Career Start Year
1994
Number of shared co-authors
1
Aw Edith Chan
The Walter and Eliza Hall Institute of Medical Research
Career Start Year
1993
Number of shared co-authors
1
Diana R Tomchick
University of Texas Southwestern Medical Center
Career Start Year
1993
Number of shared co-authors
4
Michael J Romanowski
Sunesis Pharmaceuticals, Inc. 395 Oyster Point Boulevard
Career Start Year
1993
Number of shared co-authors
5
Manfred Koegl
Boehringer Ingelheim RCV GmbH & Co. KG
Career Start Year
1993
Number of shared co-authors
1
Nikola P Pavletich
Memorial Sloan Kettering Cancer Center
Career Start Year
1991
Number of shared co-authors
3
Natarajan Kannan
University of Georgia
Career Start Year
1990
Number of shared co-authors
6
James H Hurley
University of California Berkeley
Career Start Year
1989
Number of shared co-authors
2
Ronen Marmorstein
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1987
Number of shared co-authors
2
Hediye Erdjument-Bromage
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year
1984
Number of shared co-authors
5
John Kuriyan
University of California berkeley
Career Start Year
1982
Number of shared co-authors
4
J. Wade Harper
Harvard Medical School
Career Start Year
1981
Number of shared co-authors
12
Tom Alber
University of California berkeley
Career Start Year
1976
Number of shared co-authors
7
Tom L Blundell
Heartand Lung Research Institute, University of Cambridge
Career Start Year
1971
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Cheryl H Arrowsmith
University of Toronto
Co-authored papers
13
Nathanael S Gray
Harvard Medical School
Co-authored papers
12
James E Bradner
Co-authored papers
8
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers
8
Al Ozonoff
Harvard Medical School
Co-authored papers
5
Dan H Barouch
Co-authored papers
5
Aaron D Schimmer
Princess Margaret Cancer Centre
Co-authored papers
4
Irina Bezsonova
University of Connecticut Health Center
Co-authored papers
4
Adelinda Yee
University of Toronto
Co-authored papers
4
Brian Raught
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Tom W Muir
Princeton University
Co-authored papers
3
Kenneth C Anderson
Dana Farber Cancer Institute
Co-authored papers
3
Jianwei Che
Dana-Farber Cancer Institute
Co-authored papers
3
Richard Moriggl
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers
3
Yi Zheng
Children's Hospital Research Foundation
Co-authored papers
3
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers
3
Lewis C Cantley
Co-authored papers
3
Jun Qi
Dana-Farber Cancer Institute
Co-authored papers
3
Jason Moffat
University of Toronto
Co-authored papers
2
Steven P Gygi
Harvard Medical School
Co-authored papers
2
Aled M Edwards
University of Toronto
Co-authored papers
2
Andrzej Joachimiak
Center for Structural Biology of Infectious Diseases, University of Chicago
Co-authored papers
2
Stuart Weston
University of Maryland School of Medicine
Co-authored papers
2
Nir London
The Weizmann Institute of Science
Co-authored papers
2
P??r Nordlund
Karolinska Institutet, BioClinicum J6
Co-authored papers
2
Neil T Umbreit
University of Washington
Co-authored papers
2
Walter J Chazin
and Center for Structural Biology, Vanderbilt University
Co-authored papers
2
Hee-Won Park
Kangwon National University College of Medicine
Co-authored papers
2
Holly Hammond
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers
2
Alexei Savchenko
University of Toronto
Co-authored papers
2
1 - 30